Event-Driven Stocks

Rallybio Corp

RLYBNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$858,000$600,000————
Operating income−$33.1M−$60.5M−$78.9M−$67.9M−$45.6M−$25.3M
Net income−$9.0M−$57.8M−$74.6M−$66.7M−$47.0M−$26.4M
Total assets$62.3M$68.1M$115.6M$180.4M$182.2M$141.9M
Total liabilities$4.3M$6.5M$9.4M$11.1M$6.6M$5.9M
Equity$58.0M$61.7M$106.2M$169.3M$175.6M$136.0M
EPS (diluted)$-1.59$-1.33$-1.84$-2.09$-1.84—
Shares out.41.6M37.8M38.1M32.1M32.1M23.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−3853.6%
Net margin
−1046.4%
Return on equity
−15.5%
Return on assets
−14.4%
Return on capital (ROCE)
−57.0%
Liabilities / assets
6.9%
Debt / equity
0.07×
Book value / share
$1.39
Revenue growth (YoY)
43.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
0.76distress
Accruals / assets
33.5%high accruals
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
48
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026578,7921.0-63.2%
Apr 30, 20261.6M28.9+11.9%
Apr 15, 20261.4M20.7+26.8%
Mar 31, 20261.1M10.2+39.0%
Mar 13, 2026797,8951.6+1692.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)